In lymphomas, IL-1α may have anti-tumoral properties [121], whereas IL-1β has been shown to be expressed in HL cells from areas of tissue with active fibrosis, and the receptor IL-1R2 may contribute to local and systemic modulation in the disease [120]. Here, IL1B is linked to lymphoma.